Women's Health and Pregnancy in Multiple Sclerosis.
Disease-modifying therapies
Multiple sclerosis
Neuroimmunology
Pregnancy
Women’s health
Journal
Neurologic clinics
ISSN: 1557-9875
Titre abrégé: Neurol Clin
Pays: United States
ID NLM: 8219232
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
medline:
27
11
2023
pubmed:
19
11
2023
entrez:
18
11
2023
Statut:
ppublish
Résumé
Multiple sclerosis has a 3:1 female-to-male predominance and commonly presents in young adult women. The hormonal changes in women throughout their lifetime do affect the underlying pathology of multiple sclerosis, and the needs of women therefore change with age. Although multiple sclerosis does not adversely affect fertility or pregnancy, there are many factors to consider when caring for women throughout family planning, pregnancy, and the postpartum period. The care of these women and complex decisions regarding disease-modifying therapy use in family planning should be individualized and comprehensive.
Identifiants
pubmed: 37980119
pii: S0733-8619(23)00067-1
doi: 10.1016/j.ncl.2023.07.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
275-293Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.